In vitro activity of favipiravir and neuraminidase inhibitor combinations against oseltamivir-sensitive and oseltamivir-resistant pandemic influenza A (H1N1) virus.

Tarbet, E Bart; Vollmer, Almut H; Hurst, Brett L; Barnard, Dale L; Furuta, Yousuke; Smee, Donald F

Tarbet, E Bart; Vollmer, Almut H; Hurst, Brett L; Barnard, Dale L; Furuta, Yousuke; Smee, Donald F.

Affiliation

Tarbet EB; Institute for Antiviral Research, Utah State University, Logan, UT, 84322, USA, bart.tarbet@usu.edu.

Arch Virol ; 159(6): 1279-91, 2014 Jun.

Article in En | MEDLINE | ID: mdl-24311151

Subject(s)

Amides/pharmacology; Antiviral Agents/pharmacology; Drug Synergism; Enzyme Inhibitors/pharmacology; Influenza A Virus, H1N1 Subtype/drug effects; Pyrazines/pharmacology; Animals; Cell Line; Dogs; Drug Resistance, Viral; Humans; Influenza A Virus, H1N1 Subtype/isolation & purification; Influenza, Human/virology; Microbial Sensitivity Tests; Oseltamivir/pharmacology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Pyrazines / Drug Synergism / Enzyme Inhibitors / Influenza A Virus, H1N1 Subtype / Amides Type of study: Diagnostic_studies Limits: Animals / Humans Language: En Journal: Arch Virol Year: 2014 Document type: Article Country of publication: Austria

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google